Safety

1. A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and "chemobrain" in adult cancer patients.

Fluconazole

1. A placebo-controlled, randomized, multiple-dose study examined the potential interaction of fluconazole with cisapride. (Web site)
2. Phase 1 of the study will be a placebo-controlled trial of fluconazole at a dose of 200 mg three times weekly. (Web site)
3. The effect of concomitant administration of fluconazole and glipizide has been demonstrated in a placebo-controlled crossover study in normal volunteers.

Prophylaxis

1. Placebo-controlled studies revealed an efficacy of gabapentin against pain in diabetic neuropathy and postherpetic neuralgia and in prophylaxis of migraine. (Web site)
2. Ribeiro, C. A. (2000). "L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. (Web site)
3. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. (Web site)

Prevention

1. Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial.
2. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
3. Findings from a double-blind, randomized, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) for prevention of HIV infection in women. (Web site)

Meta-Analysis

1. Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials. (Web site)
2. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials.
3. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema.

Place

1. This trial, which took place in Germany, was an open-label study, as getting approval for placebo-controlled trials in children is very difficult to obtain.

Pilot

1. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. (Web site)
2. A pilot, randomized, double-blind, placebo-controlled study.
3. To assess the benefit of the 5-HT 3 -receptor antagonist alosetron in a pilot, dose-ranging, placebo-controlled, multicentre, randomized clinical trial. (Web site)

Extracts

1. Double-blind, placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europaea pollen administered sublingually.
2. Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study.

Extract

1. A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. (Web site)
2. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. (Web site)
3. Two double-blind, placebo-controlled studies suggest that an extract of the herb butterbur may be helpful for preventing migraines.

Therapy

1. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.
2. Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study.
3. In placebo-controlled trials, discontinuation of therapy because of adverse events was required in 4.7% of patients with hypertension. (Web site)

Supplementation

1. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease: a randomized, placebo-controlled, double-blind, crossover trial.
2. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. (Web site)
3. A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. (Web site)

Weeks

1. We used a randomized, double-blind, placebo-controlled, crossover study using 6 weeks of sertraline (50 mg each morning) versus placebo. (Web site)
2. For example, in a double-blind, placebo-controlled trial, 241 seniors complaining of mildly impaired memory were given either placebo or ginkgo for 24 weeks. (Web site)
3. This will be a multi-site, double blind, placebo-controlled, two arm, parallel group, fixed-dose trial which will last 6 weeks. (Web site)

Sixty Patients

1. Sixty patients were included and entered a double - blind, placebo-controlled, cross-over study lasting 12 weeks.
2. PATIENTS AND METHODS: Sixty patients with acute tonsillitis and pharyngitis were enrolled in this randomized placebo-controlled trial. (Web site)

Double-Blind Trial

1. Clinical trial on standardized celandine extract in patients with functional epigastric complaints: Results of placebo-controlled double-blind trial. (Web site)
2. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
3. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease.

Double-Blind Trials

1. In a meta-analysis, 519 men were studied in 4 randomized, placebo-controlled, double-blind trials. (Web site)
2. EPOGEN (r) has been studied in a series of placebo-controlled, double-blind trials in a total of 131 anemic cancer patients. (Web site)

Psoriasis

1. The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial. (Web site)
2. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. (Web site)
3. There are no recent placebo-controlled trials in patients with psoriasis. (Web site)

Plaque Psoriasis

1. In placebo-controlled clinical trials in plaque psoriasis, the incidence of arthralgia was 3 percent in HUMIRA-treated patients versus 1 percent in controls. (Web site)

Lamotrigine

1. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. (Web site)
2. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. (Web site)
3. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.

Bipolar

1. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
2. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. (Web site)
3. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. (Web site)

Oxcarbazepine

1. Oxcarbazepine: double-blind, randomized, placebo-controlled, monotherapy trial for partial seizures. (Web site)
2. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
3. Several double-blind, placebo-controlled trials have evaluated oxcarbazepine in painful diabetic neuropathy and trigeminal neuralgia.

Dose-Ranging Study

1. Results of a multicenter, placebo-controlled, dose-ranging study.
2. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. (Web site)

Irritable Bowel Syndrome

1. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. (Web site)
2. Short-term treatment of the irritable bowel syndrome: a placebo-controlled trial of peppermint oil against hyoscyaminme. (Web site)
3. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. (Web site)

Blind Study

1. A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids.
2. A placebo-controlled, double blind study, tested the efficacy of Bacopa monnieri in children.
3. Randomized, placebo-controlled, double blind study. (Web site)

Active Ulcerative Colitis

1. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
2. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. (Web site)
3. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. (Web site)

Double-Dummy

1. METHODS: This was a randomized, double-blind, double-dummy, placebo-controlled, parallel- group study.

Multicenter Clinical Trial

1. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. (Web site)

Acute Ischemic Stroke

1. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study.
2. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial.
3. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. (Web site)

Pooled Data

1. The averages displayed are based on pooled data from 2 placebo-controlled, outpatient trials providing evidence of efficacy (Studies 1 and 2).

Levetiracetam

1. This is a double-blind, placebo-controlled, parallel group design study with 4 treatment groups; levetiracetam, zonisamide, topiramate, and placebo control. (Web site)
2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. (Web site)
3. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials. (Web site)

Adults

1. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. (Web site)
2. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. (Web site)
3. A large (211-participant), double-blind, placebo-controlled study found that adults with diarrhea can benefit from probiotic treatment as well. (Web site)

Respiratory Tract Infections

1. Dorn M, Knick E, Lewith G. Placebo-controlled, double-blind study of Echinacea pallidae radix in upper respiratory tract infections. (Web site)
2. Dorn M, Knick E, Lewith G. Placebo-controlled, double blind study of Echinaceae pallidae radix in upper respiratory tract infections. (Web site)
3. Placebo-controlled double-blind study of Echinacea pallidae radix in upper respiratory tract infections. (Web site)

Pilot Study

1. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. (Web site)
2. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. (Web site)
3. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. (Web site)

Chronic Fatigue Syndrome

1. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.
2. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. (Web site)
3. A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome.

Moderate

1. The antibody has been tested in an placebo-controlled, single dose, dose-escalation trial for the treatment of moderate to severe chronic plaque psoriasis. (Web site)
2. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. (Web site)
3. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. (Web site)

Alzheimer Disease

1. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. (Web site)
2. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.
3. Knopman D, Kahn J, Miles S. Clinical research designs for emerging treatments for Alzheimer disease: moving beyond placebo-controlled trials.

Double-Blind Study

1. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. (Web site)
2. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study.
3. Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication.

Double-Blind Studies

1. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. (Web site)
2. Covera-HS was evaluated in two placebo-controlled, parallel design, double-blind studies of 382 patients with mild to moderate hypertension. (Web site)

Sleep

1. Sodium oxybate relieves pain and improves sleep in fibromyalgia syndrome (FMS): a randomized, double-blind, placebo-controlled, multi-center clinical trial. (Web site)
2. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.

Melatonin

1. Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study.
2. Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study.
3. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Effectiveness

1. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. (Web site)
2. To establish the effectiveness of a treatment, it must be put through a double-blind, placebo-controlled trial. (Web site)
3. Their study involved 3,385 women enrolled in a randomized, placebo-controlled study to evaluate the effectiveness of tamoxifen after surgery.

Randomized Clinical Trial

1. Results of a double-blind, placebo-controlled, randomized clinical trial. (Web site)
2. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
3. DESIGN: Double-blind, placebo-controlled, randomized clinical trial. (Web site)

Depression

1. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
2. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). (Web site)
3. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Paroxetine

1. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
2. Lamotrigine as adjunct to paroxetine in acute [unipolar]depression: A placebo-controlled, double-blind study. (Web site)
3. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. (Web site)

Gabapentin

1. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. (Web site)
2. PATIENTS AND METHODS: We administered gabapentin in a placebo-controlled, double-blind, crossover trial to 19 subjects with advanced parkinsonism.
3. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. (Web site)

Multi-Center

1. The most recent acute symptom control study was a multi-center, randomized, placebo-controlled, double-blind, parallel-group study (n=636). (Web site)
2. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. (Web site)
3. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: A multi-center, double-blind, randomized and placebo-controlled study in Taiwan.

Multicentre Trial

1. Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease. (Web site)

Categories

1. Double-Blind
2. Randomized
3. Randomised
4. Study
5. Trial

Related Keywords

* Blind * Clinical * Clinical Trial * Clinical Trials * Cross-Over Study * Crossover * Crossover Study * Crossover Trial * Dementia * Design * Disorder * Double-Blind * Double-Blinded * Double-Blind Clinical Trial * Double-Blind Placebo-Controlled Trial * Effect * Efficacy * Fibromyalgia * Functional Dyspepsia * Intermittent Claudication * Migraine * Multicenter * Multicenter Study * Multicenter Trial * Multicentre * Multicentre Study * Osteoarthritis * Parallel-Group * Patients * Phase * Placebo * Placebo-Controlled Clinical Trial * Placebo-Controlled Multicenter Study * Placebo-Controlled Trial * Prospective * Randomised * Randomized * Randomized Study * Randomized Trial * Results * Sclerosis * Smoking Cessation * Study * Symptoms * Treatment * Trial * Trials

1. Books about "Placebo-Controlled" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -